Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Program source : Www.biospace.com save search
Biotricity Launches Major Cardiac Monitoring Pilot Program in a Hospital System Comprised of 9 Hospitals and 10 Clinics
Published: 2024-04-18 (Crawled : 13:00) - biospace.com/
BTCY | $1.29 1.58% 1.55% 140K
|
Manufacturing
|
| O: 7.5%
H: 0.0%
C: 0.0%
cardiac hospital system program pilot
Asher Bio Closes $55 Million Series C Financing to Advance Lead Program into Phase 1b Clinical Trials
Published: 2024-04-16 (Crawled : 14:00) - biospace.com/
AZN | $68.36 -0.25% -0.25% 4M
|
Health Technology
|
| O: -0.64%
H: 0.45%
C: -0.04%
million series trials program
Elevation Oncology Presents Preclinical Proof-of-Concept Data for HER3-ADC Program at AACR Annual Meeting 2024
Published: 2024-04-08 (Crawled : 23:00) - biospace.com/
ELEV | $4.03 -2.66% -2.73% 320K
|
Professional, Scientific, and T...
|
| O: -3.87%
H: 0.0%
C: 0.0%
preclinical for meeting program
BrainStorm Cell Therapeutics to Provide Update on NurOwn Program
Published: 2024-04-08 (Crawled : 12:00) - biospace.com/
BCLI | $0.503 -6.99% -7.51% 1.1M
|
Health Technology
|
| O: -0.37%
H: 0.0%
C: 0.0%
update cell nurown program therapeutics
CureVac Announces Promising Phase 2 Interim Data from Seasonal Influenza Vaccine Development Program in Collaboration with GSK
Published: 2024-04-04 (Crawled : 12:30) - biospace.com/
CVAC | $2.44 -5.06% -5.33% 710K
|
Health Technology
|
| O: 2.79%
H: 2.03%
C: 0.34%
vaccine influenza collaboration program
Biological Dynamics Announces Expanding Adoption of ExoVerita™ Pro Under Early Access Program
Published: 2024-04-02 (Crawled : 14:30) - biospace.com/
FNCTF | News | $11.0354 -20.84% 34K
|
Communications
|
| O: -100.0%
H: NaN%
C: Infinity%
pro program
Blackstone Life Sciences Announces Collaboration to Support Moderna’s Influenza Program
Published: 2024-03-27 (Crawled : 12:00) - biospace.com/
BX | $120.32 -2.33% -0.49% 5.7M
|
Finance
|
| O: 1.27%
H: 1.14%
C: 1.07%
MRNA | News S | $102.015 -1.38% -1.4% 1.7M
|
Health Technology
|
| O: 2.02%
H: 1.41%
C: 0.92%
life influenza sciences collaboration program
Arrowhead Pharmaceuticals Initiates Expanded Access Program for Plozasiran and Announces Upcoming Presentation of Clinical Data
Published: 2024-03-25 (Crawled : 13:30) - biospace.com/
ARWR | $22.62 0.4% 0.4% 1.3M
|
Health Technology
|
| O: 0.37%
H: 2.34%
C: 2.12%
presentation pharmaceuticals program
Cybin Announces Positive End-of-Phase 2 Meeting with FDA for CYB003 in Major Depressive Disorder and Phase 3 Program Design
Published: 2024-03-14 (Crawled : 12:30) - biospace.com/
CYBN | $0.3699 -1.47% 1.05% 1.7M
|
n/a
|
| O: 7.14%
H: 5.53%
C: -4.67%
cyb003 fda positive meeting program design
Citius Pharmaceuticals, Inc. Secures $2.4 million through New Jersey Economic Development Program
Published: 2024-03-07 (Crawled : 14:30) - biospace.com/
CTXR | $0.8 -1.99% -2.02% 6.3M
|
Health Technology
|
| O: 0.7%
H: 4.13%
C: 3.61%
million program
Precision BioSciences Announces MHRA Approval for Partner iECURE to Expand Phase 1/2 Clinical Trial of ARCUS Gene Editing Program in OTC Deficiency
Published: 2024-03-06 (Crawled : 14:30) - biospace.com/
DTIL | $10.77 -6.43% -6.87% 71K
|
Health Technology
|
| O: 1.56%
H: 3.55%
C: 0.81%
precision approval arcus program trial
Lantern Pharma Advances Unique ADC (Antibody Drug Conjugate) Program Across Multiple Solid Tumor Cancers
Published: 2024-02-15 (Crawled : 15:00) - biospace.com/
LTRN | $5.87 -2.0% -2.04% 110K
|
Health Technology
|
| O: -0.25%
H: 3.17%
C: -0.74%
pharma drug unique tumor program
Salix Announces 2024 Gastrointestinal Health Scholars Program
Published: 2024-02-12 (Crawled : 13:30) - biospace.com/
BHC | $8.6 -0.69% 0.0% 2.1M
|
Health Technology
|
| O: 0.24%
H: 3.28%
C: 1.82%
health program gastrointestinal
Cybin Announces Grant of Two Additional Patents in Japan in Support of its DMT Program
Published: 2024-02-07 (Crawled : 13:30) - biospace.com/
CYBN | $0.3699 -1.47% 1.05% 1.7M
|
n/a
|
| O: 1.42%
H: 0.0%
C: -10.34%
japan grant program
Vertex Announces Positive Results From the VX-548 Phase 3 Program for the Treatment of Moderate-to-Severe Acute Pain
Published: 2024-01-30 (Crawled : 12:30) - biospace.com/
VRTX | $393.51 0.1% 0.1% 950K
|
Health Technology
|
| O: -1.34%
H: 4.28%
C: 3.74%
vx-548 positive treatment program results
NAYA Biosciences To Acquire Clinical Stage Gene Therapy Program for Leber's Hereditary Optic Neuropathy (LHON)
Published: 2024-01-23 (Crawled : 15:30) - biospace.com/
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
|
| O: 3.88%
H: 9.35%
C: 2.8%
acquire program therapy
InnoCare Announces First Prescription of Tafasitamab in Combination with Lenalidomide for Relapsed or Refractory Diffuse Large B-Cell Lymphoma Under Greater Bay Area’s Early Access Program
Published: 2024-01-22 (Crawled : 07:00) - biospace.com/
XNCR | $18.98 -0.47% -0.47% 470K
|
Health Technology
|
| O: 0.56%
H: 1.97%
C: 1.37%
MOR | News | $18.02 -0.11% -0.11% 590K
|
Health Technology
|
| O: 0.11%
H: 1.96%
C: -0.27%
first bay program
bluebird bio Provides Update on Commercial Launch Progress, Program Milestones, and 2024 Financial Outlook
Published: 2024-01-08 (Crawled : 18:00) - biospace.com/
BLUE | $0.9583 -0.52% -0.52% 6.5M
|
Health Technology
|
| O: 0.7%
H: 3.85%
C: 2.8%
update commercial program financial
Marker Therapeutics Announces Clinical Program Updates and Pipeline Prioritization
Published: 2024-01-08 (Crawled : 14:30) - biospace.com/
MRKR | $4.24 -1.62% -1.65% 13K
|
Consumer Services
|
| O: -1.87%
H: 7.82%
C: 4.44%
pipeline program therapeutics
CureVac Announces Positive Phase 2 Interim Data from COVID-19 Vaccine Development Program in Collaboration with GSK Providing Strong Validation of Proprietary Technology Platform
Published: 2024-01-05 (Crawled : 13:30) - biospace.com/
CVAC | $2.44 -5.06% -5.33% 710K
|
Health Technology
|
| O: 0.71%
H: 4.24%
C: 2.12%
covid-19 vaccine positive collaboration program technology platform
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.